People
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
8 November 2024 - WuXi XDC Cayman Inc (HK: 2268), a China-based global CRDMO (Contract Research, Development, and Manufacturing Organisation) specialising in antibody-drug conjugates (ADCs) and other ...
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business
5 November 2024 - Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company focused on the discovery and development of novel therapies to treat autoimmune disorders, announced on Monday that it has...
Insmed receives highest ranking in Science's 2024 Top Employers Survey
25 October 2024 - US-based biopharmaceutical company Insmed Incorporated (Nasdaq:INSM) announced on Thursday that it has received the highest ranking in Science journal's 2024 Top Employers Surve...
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions
18 October 2024 - Pharmaceutical company OncoZenge AB (publ) (STO:ONCOZ) announced on Friday plans to partner with Pharmanovia for exclusive commercialization rights of BupiZenge in Europe, the Middle...
Viatris added to Forbes' World's Best Employers 2024 list
9 October 2024 - US-based global healthcare company Viatris Inc (NASDAQ: VTRS) announced on Tuesday that has been added to Forbes' list of World's Best Employers 2024.This is the fourth cons...
Rarity Health named finalist for 21st MM+M Rare Disease Agency of the Year
24 September 2024 - New Jersey-based healthcare communications agency Rarity Health announced on Monday that it has been named an agency finalist for the 21st MM+M Rare Disease Agency of the Year.MM+M...